6th trends in medical mycology tivoli hotel & congress center

Organised by

2nd announcement www.TIMM2013.org

6th Trends in Medical Mycology11 – 14 October 2013

Tivoli Hotel & Congress Center Copenhagen, Denmark

Important dates15 April 2013 early registration fee deadline1 June 2013 abstract deadline1 July 2013 confirmation of abstract acceptance 1 August 2013 late breaking abstracts deadline*9 September 2013 regular registration fee deadline*for information on late breaking abstract requirements see www.timm2013.org

See the congress website for the latest information:

www.TIMM2013.orgTrends in Medical Mycology is the bi-annual joined meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and European Confederation of Medical Mycology (ECMM)

TIMM-6 is supported with unrestricted grants by the following major sponsors:

www.TIMM2013.org

Congress CareP.O. Box 4405201 AK ‘s-HertogenboschThe NetherlandsTel [email protected]

1

IntroductionDear Friends and Colleagues,

It is a great pleasure for us to invite you to attend the 6th Congress on Trends in Medical Mycology (TIMM-6), which will be held at the brand new Tivoli Congress Centre in Copenhagen, Denmark, 11- 14 October 2013. TIMM-6 is the 6th in the series of TIMM mycological international meetings organised jointly by the European Confederation of Medical Mycology (ECMM) and the Infectious Diseases Group of the European Organisation for Research and Treatment of Cancer (IDG-EORTC). TIMM has become an important and essential meeting in the field of fungal infections, a forum in which researchers from all over the world present the most important advances and research findings in mycology from basic science to clinical research. It is thus a unique opportunity to get updated on the most recent results and opinions on medical practice.

The outstanding scientific programme will include plenary sessions on fungal infections in all aspects of immunocompromised hosts chaired by an internationally renowned faculty, round table sessions, and meet-the-expert sessions. The poster session will encourage one-to-one discussions between faculty, presenters and delegates. The meeting is designed for infectious disease specialists, haematologists, oncologists, transplant physicians, microbiologists, intensivists, immunologists, dermatologists, paediatricians, and all those with interests in medical mycology. At the end of the meeting we hope that every participant has learned something new, has been refreshed on something old and has had the opportunity to meet other colleagues within the field of medical mycology.

The venue for TIMM-6 is located in Copenhagen, Denmark. Copenhagen is a vibrant metropolis, the gateway to Scandinavia and amongst the safest and cleanest cities in the world. This beautiful city by the water offers both a wide variety of cultural experiences and stunning architecture within its compact city centre. You can reach Copenhagen Airport on non-stop flights from more than 130 destinations and from the airport it takes a mere 12 minutes to get to the city centre by train or metro – faster than in any other European capital.

Medieval townhouses in a variety of colours and atmospheric streetlamps reflecting in the cobble stones await your delegates in the old city centre. Denmark is the oldest monarchy in the world. Beautiful traces of Copenhagen’s 1,000-year history are to be found everywhere. Through the years, however, Copenhagen has transformed itself into one of the world’s leading design capitals. Award-winning contemporary architecture and stunning design appear all over the city. The Copenhagen Night of Culture 2013 will on 11 October present a sensational programme for all tastes. Museums, libraries, educational establishments, theatres, musical venues, churches and many other institutions representing art and culture will keep their doors open during the evening from six o’clock to midnight or beyond. Many of Culture Night’s 500 events are being arranged specially for this evening offering you an experience out of the ordinary.We expect TIMM-6 to be at least as successful as previous TIMM congresses, which brought together more than 1,000 international delegates from all over the world. We look forward to greeting you in Denmark and discuss new developments in medical mycology!

Maiken Cavling Arendrup, Cornelia Lass-Flörl, Ditte Marie Saunte and Paul Verweij TIMM-6 Executive Committee

2

www.TIMM2013.org

Congress secretariatCongress CareP.O. Box 4405201 AK ‘s-HertogenboschThe NetherlandsTel [email protected]

2 3

Committees

Executive committeeMaiken Cavling ArendrupDitte Marie SaunteCornelia Lass-FlörlPaul Verweij

Nordic Scientific CommitteeDenmarkJens ShierbeckHelle Krogh Johansen

FinlandHarri SaxenPentti KuuselaEira Poikonen

NorwayIngvild Nordøy

SwedenLena KlingsporPer LjungmanErja Chryssanthou

International scientific committeeRosemary Barnes, United KingdomPeter Donnelly, The NetherlandsNikolay Klimko, RussiaKatrien Lagrou, BelgiumOlivier Lortholary, FranceOscar Marchetti, SwitzerlandGeorg Maschmeyer, GermanyZekaver Odabasi, TurkeyLivio Pagano, ItalyPeter Pappas, USAJavier Pemán, SpainGuillermo Quindós, SpainJános Sinkó, HungaryJacek Szepietowski, PolandAndrew Ullmann, Germany

4 5

The programme at a glance

Saturday 12 October 2013 Sunday 13 October 2013 Monday 14 October 2013

9:00 - 10:00 Plenary session 2 Top 10 papers

Plenary session 3Clinical pharmacology in treatment of invasive mycoses

Plenary session 4The present and future of diagnostic and antifungals

10:00 - 10:15 Coffee break Coffee break Coffee break

10:15 - 11:00 Meet-the-expert sessions M1 Malassezia infectionsM2 MucormycosisM3 Susceptibility testing using

commercial testsM4 MALDI-TOFM5 Definitions and response criteria

Meet-the-expert sessions M6 Solid organ transplant patientsM7 Epidemiology of antifungal drug resistance M8 Fungal typing methods M9 Risk assessment of the ICU patientM10 Biomarkers

Meet-the-expert sessions M11 Tinea capitisM12 Update of non-culture methods for laboratory

identification of fungal infections M13 Promises and pitfalls of diagnostic PCRM14 Risk assessment in the haemato-oncologic patientM15 Difficult cases in medical mycology

11:00 - 12:00 Poster session Poster session Plenary session 5Cryptococcus and travel related mycoses

12:00 - 14:15 Lunch break Lunch break Closing

12:30 - 14:00 Integrated symposium 3 - Pfizer Integrated symposium 5 - Astellas

14:15 - 15:45 Workshops 5-7 and Free Communications 1W5 PK/PDW6 Challenges in the management of IFI

in the ICUW7 Mucocutaneous candidosisFree communications 1

Workshops 12-15 and Free Communications 3W12 Molecular diagnosisW13 Guidelines or personalised medicineW14 Rare fungal pathogens - upcoming guidelinesW15 Onychomycosis Free communications 3

15:45 - 16:15 Coffee break Coffee break

16:15 - 17:45 Workshops 8-11 and Free Communications 2W8 Host fungus interactionW9 Cystic fibrosisW10 What's in a name?W11 Workshop Nordic Society of Medical

Mycology - Candidaemias in Northern Europe - world's apart?

Free communications 2

Workshops 16-19 and Free Communications 4W16 Facing old and current issues in haemato-oncologyW17 Resistance & susceptibility testingW18 Pneumocystis infectionW19 From model to manFree communications 4

18:15 - 19:45 Integrated symposium 4 - Gilead Ben De Pauw Lecture (EORTC)

Congress dinner

Friday 11 October 2013

9:45 - 11:45 ECMM council meeting

9:00 - 11:45 Working group meetings

12:00 - 13:15 Plenary Session 1Global fungal threats

13:30 - 15:00 Workshops 1-4W1 Dermatophyte infections - an

updateW2 Diagnosing pulmonary fungal

infectionsW3 Focal & ENT fungal infections W4 Paediatric mycoses:

Where are we today?

15:15 - 16:45 Sponsored diagnostic sessions

17:00 - 18:30 Integrated symposium 2 - MSD

18:45 - 19:15 Opening ceremony

19:15 E. Drouhet lecture (ECMM)

6

TIMM-6 Scientific Programme

Friday 11 October 2013

9:45 - 11:45 ECMM council meeting

12:00 - 13:15 Plenary Session 1: Global fungal threats12:00 Global fungal burden David Denning, UK12:30 Emerging fungal threats to animal, plant and ecosystem health Matthew Fischer, UK12:45 Discussion

13:30 - 15:00 Workshops 1-4

Workshop 1 Dermatophyte infections - an update13:30 Epidemiology (which species where and when) Jan Faergemann, Sweden13:50 Same fungus, new names? Yvonne Gräser, Germany14:10 Classical versus non-culture based diagnostics Michael Arabatzis, Greece 14:30 Clinical management Rod Hay, UK14:50 Discussion

Workshop 2 Diagnosing pulmonary fungal infections13:30 BAL procedures; need for standardisation? Christian Geltner, Austria 13:50 BAL galactomannan interpretation Johan Maertens, Belgium14:10 Lung biopsies and how to improve diagnosis? Cornelia Lass-Flörl, Austria 14:30 Imaging options Claus-Peter Heussel, Germany14:50 Discussion

Workshop 3 Focal & ENT fungal infections 13:30 Mycosis of the eye t.b.a.13:55 Otomycosis Jagdish Chander, India14:20 Sinusitis Arunaloke Chakrabarti, India14:45 Discussion

6 7

Workshop 4 Paediatric mycoses: Where are we today?13:30 Changes in epidemiology Theoklis Zaoutis, USA13:55 Advances in diagnosis Andreas Groll, Germany14:20 Treatment and prophylaxis: which kids, drugs and dosages? Thomas Lehrnbecher, Germany14:45 Discussion

15:15 - 16:45 Sponsored diagnostic sessions

17:00 - 18:30 Integrated symposium 2 – Sponsored by Merck Sharp & Dohme

18:45 Opening ceremony

19:15 E. Drouhet lecture (ECMM)

19:45 Welcome reception

Saturday 12 October 2013

9:00 - 10:00 Plenary session 2: Top 10 papers9:00 Diagnostics Malcolm Richardson, UK9:30 Clinical mycology Bart-Jan Kullberg, The Netherlands

10:00 - 10:15 Coffee break

10:15 - 11:00 Meet-the-expert sessions

M.1 Malassezia infections George Gaitanis, Greece and Jan Faergemann, SwedenM.2 Mucormycosis Anna Skiada, Greece and Emmanuel Roilides, GreeceM.3 Susceptibility testing using commercial tests Maiken Cavling Arendrup, Denmark and Michael Pfaller, USAM.4 MALDI-TOF Brunella Posteraro, Italy and Teun Boekhout, The NetherlandsM.5 Definitions and response criteria Peter Donnelly, The Netherlands and Catherine Cordonnier, France

8

11:00 - 12:00 Coffee break and Poster session 1

12:00 - 14:15 Lunch break

12:30 - 14:00 Integrated symposium 3 - Sponsored by Pfizer

14:15 - 15:45 Workshops 5-7 and Free communications 1

Workshop 5 Pharmacokinetic / Pharmacodynamic14:15 PKPD made simple! David Andes, USA14:35 PKPD: an ingredient in clinical breakpoint setting William Hope, UK14:55 Why is it important for the clinician? Werner Heinz, Germany15:15 Therapeutic Drug Monitoring (TDM) Roger Brüggemann, The Netherlands15:35 Discussion

Workshop 6 Challenges in the management of IFI in the ICU14:15 Fungal epidemiology Robert Krause, Austria14:35 Prophylaxis, empirical, preemptive therapy? Wouter Meersseman, Belgium14:55 Getting the dose right Kevin Garey, USA15:15 Catheter management Jesús Guinea Ortega, Spain 15:35 Discussion

Workshop 7 Mucocutaneous candidosis14:15 Recurrent Vulvo Vaginal Candidiasis (RVVC) - update on epidemiology and

treatment Gilbert Donders, Belgium14:40 Immunity and mucocutanous candidosis Peter Zipfel, Germany15:05 Oral candidosis Riina Richardson, UK15:30 Discussion

Free communications 1 (selected abstracts)


8 9


Workshop 8 Host fungus interaction16:15 Host genetics and candida infections Frank van de Veerdonk, The Netherlands16:35 Host genetics and aspergillus infections Pierre Bochud, Switzerland16:55 Immune response Luigina Romani, Italy17:15 Pathogenesis Jean-Paul Latgé, France17:35 Discussion

Workshop 9 Cystic fibrosis16:15 Aspergillus and resistance Jacques Meis, The Netherlands 16:35 Weird moulds: pathogenic or innocent bystanders? Jean-Paul Bouchara, France16:55 Diagnostic of fungal colonisation/infection Michaela Lackner, Austria17:15 Management of fungal colonisation/infection Frank-Michael Müller, Germany17:35 Discussion

Workshop 10 What's in a name?16:15 Epidemiology based on new taxonomy Katrien Lagrou, Belgium16:35 One fungus, one name Rob Samson, The Netherlands16:55 Implications for the medical laboratory Rosemary Barnes, UK17:15 Implications for the clinician Olivier Lortholary, France17:35 Discussion

Workshop 11 Workshop Nordic Society of Medical Mycology – Candidaemias in Northern Europe – world's apart?

16:15 Epidemiology of candidaemia in Northern Europe Eira Poikonen, Finland16:35 Antifungal use: Notable differences in prescription practises and

association to epidemiology Liv Hesstvedt, Norway16:55 Use of antifungals in animals and agriculture - any impact on human

infections? Henrik Elvang Jensen, Denmark and Lise Nistrup Jørgensen, Denmark

10

17:15 Implications for current practises and recommendations? Lena Klingspor, Sweden17:35 Discussion


18:15 - 19:45 Integrated symposium 4 - Sponsored by Gilead

Sunday 13 October 2013

9:00 - 10:00 Plenary Session 3: Clinical pharmacology in treatment of invasive mycoses Which antifungal for which site of infection? Johan Mouton, The Netherlands Personalised antifungal treatment William Hope, UK



M.6 Solid organ transplant patients Martin Iversen, Denmark and José Aguado, SpainM.7 Epidemiology of antifungal drug resistance Sevtap Arikan, Turkey and Alicia Gómez López, SpainM.8 Fungal typing methods Corné Klaassen, The Netherlands and Anna Brillowska-Dąbrowska, PolandM.9 Risk assessment of the ICU patient Sergio Ruiz-Santana, Spain and Luis Ostrosky-Zeichner, USA M.10 Biomarkers Oscar Marchetti, Switzerland and Boualem Sendid, France

11:00 - 12:00 Coffee break and Poster session 2

12:00 - 14:15 Lunch break

12:30 - 14:00 Integrated symposium 5 - Sponsored by Astellas


Workshop 12 Molecular diagnosis14:15 Diagnostic PCRs Manuel Cuenca-Estrella, Spain14:35 EAPCRI, where do we stand? Lewis White, UK

10 11

14:55 Direct detection of resistance: candins vs. azoles David Perlin, USA15:15 New generation sequencing, any use? Stéphane Bretagne, France15:35 Discussion

Workshop 13 Guidelines or personalised medicine14:15 Overview of guidelines Claudio Viscoli, Italy14:40 Pro: I need guidelines Murat Akova, Turkey15:05 Con: one guideline doesn't fit all Christopher Kibbler, UK15:30 Discussion

Workshop 14 Rare fungal pathogens - upcoming guidelines14:15 Zygomycetes Oliver Cornely, Germany14:35 Rare yeasts Olivier Lortholary, France14:55 Hyalohyphomycetes Anna Maria Tortorano, Italy15:15 Phaeohyphomycosis Anuradha Showdhary, India15:35 Discussion

Workshop 15 Onychomycosis 14:15 Epidemiology Jochen Brasch, Germany14:35 Antifungal treatment Bardur Sigurgeirsson, Iceland14:55 Antifungal resistance Mahmoud Ghannoum, USA15:15 The role of surgical intervention Bertrand Richert, Belgium15:35 Discussion



12


Workshop 16 Facing old and current issues in Haemato-oncology16:15 Management of breakthrough IFI Georg Maschmeyer, Germany16:35 What is the role of granulocyte transfusion and colony stimulating growth

factors? Livio Pagano, Italy16:55 Lymphocyte defects and IFD in transplant setting Andrew Ullmann, Germany17:15 Invasive aspergillosis: How to improve clinical outcome Oliver Cornely, Germany17:35 Discussion

Workshop 17 Resistance & susceptibility testing16:15 Candida & candins Maiken Cavling Arendrup, Denmark16:35 Aspergillus & azoles Paul Verweij, The Netherlands16:55 Fungal pesticides implications for human health Lise Nistrup Jørgensen, Denmark17:15 CSLI vs. EUCAST breakpoints Shawn Lockhart, USA17:35 Discussion

Workshop 18 Pneumocystis infection 16:15 Taxonomy and epidemiology Olga Matos, Portugal16:40 Clinical presentation and management Silke Neumann, Germany 17:05 Diagnosis from conventional to molecular based techniques Jannik Helweg-Larsen, Denmark 17:30 Discussion

Workshop 19 From model to man16:15 In vitro models Joseph Meletiadis, Greece16:40 Non-vertebrate models Dimitrios Kontoyiannis, USA17:05 Animal models: from cage to bedside Peter Warn, UK17:30 Discussion

12 13


18:15 - 19:45 Ben De Pauw Lecture (EORTC)

Congress Dinner

Monday 14 October 2013

9:00 - 10:00 Plenary session 4: The present and future of diagnostics and antifungals9:00 The landscape of antifungals: the present and future John Rex, USA9:30 The landscape of diagnostics: the present and future Alex van Belkum, France



M.11 Tinea capitis Gabriele Ginter-Hanselmayer, Austria and Ditte Marie Saunte, Denmark/USAM.12 Update of non-culture methods for laboratory identification of fungal infections Guillermo Quindós, Spain and Tom Rogers, IrelandM.13 Promises and pitfalls of diagnostic PCR Willem Melchers, The Netherlands and Stéphane Bretagne, FranceM.14 Risk assessment in the haemato-oncologic patient Martin Hönigl, Austria and Markus Ruhnke, GermanyM.15 Difficult cases in medical mycology Patricia Muñoz, Spain and Matteo Bassetti, Italy

11:00 - 12:00 Plenary session 5: Cryptococcus and travel related mycoses11:00 Cryptococcus infections Tom Harrison, UK11:30 Travel related mycosis for the European na(t)ives Peter Pappas, USA

12:00 Closing

14

Call for abstracts

The TIMM Scientific Committee would like to encourage authors to submit their abstracts through the congress website, which hosts an electronic abstract submission form. The congress website can be consulted at www.TIMM2013.org.

Submission deadline: 1 June 2013

Late breaker abstractsLate breaker abstracts will only be considered if there is new information on the epidemiology, diagnosis or management of fungal infections that should be brought to the attention of conference because it is timely and will likely have an impact on the conference topics and the mycology community at large. Late breaking abstracts can be sent until 1 August to [email protected]

ECMM Young Investigators Travel AwardsThe ECMM Young Investigators Travel Award facilitates young, non-established investigators in medical mycology to make educational or practical study visits to medical mycology oriented departments or institutions in other European countries. As a rule, the Awardee will be selected from among those presenting a poster in the TIMM Congress.An outstanding oral presentation may also be considered. The ECMM will present 4 Travel Awards.The presentations are selected by a Prize Committee on the basis of the scientific quality, including novelty, reliability and significance, of the Awardee's presentation. The sum per Award is presently EUR 1000, to support the travel and living costs of one week. The institute visited is freely selected by the Awardee.Eligibility: The Award is intended for young (not older than 35 years) persons who are citizens of European countries or work in Europe. The Awardee should not hold an established (other than grant funded) post in medical mycology. It is also wished that the Awardee is a member of a society for mycology or at least aims to apply for membership.Eligible first or presenting authors are preferred, but an outstanding team may be selected if it can direct the Award to junior co-authors who are eligible. These individuals and teams wishing to be considered as candidates of the Award in the 6th TIMM congress in Copenhagen 2013, are kindly asked to fill out the form which they can find on the congress website and submit it to the Congress secretariat at first convenience.

14 15

Social Programme

For registered participants:

Friday 11 October 2013 19:45 hrs. Welcome reception at the Tivoli Congress Center.

Sunday 13 October 2013Congress dinner and festive evening. Your evening will start with a boat trip from the Congress Centre to trendy Toldboden Restaurant. Toldboden is located in the old harbour and close to the city centre. This exclusively designed restaurant offers a tasty selection of good old-fashioned homemade cooking using seasonal products mixed with Scandinavian New Nordic Cuisine.

After you have enjoyed your tasteful dinner you may either stay, enjoy the live music and some dancing or take a shuttle bus back to one of the congress hotels.

Registration fee: 125 EUR per delegate

Please note: you have to register and pay in advance for the congress dinner.Additional dinner tickets maybe purchased at 125 EURO per ticketDay tours can be booked via International Conference Services on-site.

16

Registration

Registration fee Before Untill After 9 Sept 2013 15 April 2013 9 Sept 2013 and on-siteECMM/EORTC- members EUR 525 EUR 775 EUR 1075Non-members EUR 750 EUR 1045 EUR 1275Physicians/scientists in training* EUR 425 EUR 525 EUR 600Day registration EUR 400 EUR 525 EUR 575Emerging Economy Rate** EUR 250 EUR 250 EUR 300

* Physicians/scientists in training have to provide a written certification by the head of department.

** Emerging Economy Rate is applied to individuals (no group registrations) from low-income and lower-middle-income economies according to the World Bank listing available at the website of the World Bank. See www.timm2013.org for more information.

What is included in the registration fee?The registration fee for delegates includes:Admission to the meeting, welcome reception, program and abstract book, certificate of attendance, 2 lunches and all coffee breaks.

Congress dinner SundayDinner tickets (125 EUR): please make your reservation when you register online.

How to register and payPlease register online, online payment possible (Mastercard, Visa).

Group registrationsFor group registrations; please contact the congress secretariat via: [email protected], before starting your group registration.

CancellationCancellations and refund requests must be submitted in writing to the congress secretariat. Cancellations made before 1 July 2013 will be refunded less 30% to cover administration costs. After this date no refunds will be given. All refunds will be madeafter the congress.

16 17

Hotel Accommodation

The hotel booking service agency International Conference Services A/S is officially appointed by the organisation. On the website www.TIMM2013.org you can easily select and book your hotel.

Please contact the housing agency directly for group hotel booking requests.

International Conference Services A/SP.O. Box 41, Strandvejen 169-171DK-2900 Hellerup, [email protected] Tel +45-3946-0520 Fax +45-3946-0515

Prefered CarrierSAS Airlines offers conference discounts to the delegates, guest speakers, exhibitors, etc. travelling to and from TIMM/Copenhagen.Please visit www.timm2013.org for relevant info (booking tool, discountcode).

18

General Information

CME accreditationAccreditation is applied for at the European Accreditation Council for Continuing Medical Education (EACCME). This accreditation will be endorsed by the European Union of Medical Specialists (UEMS) ensuring that the CME credits awarded to the participants are recognized by the national medical authorities who have agreed to co-operate in this European system. EACCME credits are recognized by the American Medical Association towards the Physician's Recognition Award (PRA).

LocationTIMM-6 will be held in the modern Tivoli Hotel & Congress Center. Copenhagen’s new Tivoli Congress Centre is located in the heart of the city - just around the corner of the Central Station, and within walking distance of the hotels, shops and attractions. From Copenhagen Airport, you can conveniently board the train for Copenhagen Central Station.

ClimateIn October the climate in Copenhagen is mild. The average temperature is 15oC. As night-time temperatures can fall below 6oC, an extra layer of clothing is recommended.

TimingThe congress will start on Friday 11 October 2013 with registration, symposia, keynote lectures, sponsored symposia, opening ceremony and welcome reception. The congress will end on Monday 14 October 2013 at noon.

Letter of invitationThe organizers will be pleased to send a letter of invitation to any individual requesting one, once their registration form and fee have been received. It is to be understood that such an invitation is intended to help potential participants raise travel funds or obtain a visa. It is not a commitment on the part of the congress to provide any financial support. Applications have to be received by the conference secretariat before 2 September 2013. Visa refusal is no reason for refund.

Exhibition and sponsored symposiaDuring the conference an industrial exhibition will be arranged. A targeted group of biotechnic, diagnostic and pharmaceutic companies will be invited to organize a sponsored symposium and exhibit their products and services.

InsuranceIn registering for the 6th Trends in Medical Mycology delegates agree that neither the organisation nor the congress agency Congress Care is responsible for individual medical, travel or personal insurance. Delegates are requested to arrange their own travel and health insurance. The organizers cannot assume liability for changes in the program due to external circumstances.

WebsiteFurther information is available on: www.TIMM2013.org

18 19

Sponsors TIMM6 (March, 2013)

AdvanDxAssociates of Cape Cod Inc.Astellas Pharma Europe LtdGilead Sciences Europe Ltd.Lab21 HealthcareMerck Sharp & DohmeOLM Medical LtdPfizer EuropeSSI Diagnostica

www.TIMM2013.org

Important dates15 April 2013 early registration fee deadline1 June 2013 abstract deadline1 July 2013 confirmation of abstract acceptance 1 August 2013 late breaking abstracts deadline*9 September 2013 regular registration fee deadline*for information on late breaking abstract requirements see www.timm2013.org

See the congress website for the latest information:

www.TIMM2013.orgTrends in Medical Mycology is the bi-annual joined meeting of the Infectious Disease Group of the European Organisation for Research and Treatment of Cancer (EORTC) and European Confederation of Medical Mycology (ECMM)

TIMM-6 is supported with unrestricted grants by the following major sponsors:

www.TIMM2013.org

Congress CareP.O. Box 4405201 AK ‘s-HertogenboschThe NetherlandsTel [email protected]

Organised by

2nd announcement www.TIMM2013.org

6th Trends in Medical Mycology11 – 14 October 2013

Tivoli Hotel & Congress Center Copenhagen, Denmark

6th trends in medical mycology tivoli hotel & congress center

Documents